Thymosin-α1 Binds ACE, Reduces ACE2 in Respiratory Cells
Background
The renin-angiotensin system (RAS) plays a crucial role in regulating blood pressure and fluid balance, with angiotensin-converting enzyme (ACE) and angiotensin-converting enzyme 2 (ACE2) being key components. ACE2 is particularly important as a receptor for certain viruses, including SARS-CoV-2, on respiratory epithelial cells. While Thymosin-α1 is known for its immunomodulatory effects, its direct interaction with the ACE/ACE2 axis in human respiratory cells has not been fully elucidated.
Results
The study confirmed a direct physical interaction, showing that Thymosin-α1 specifically binds to ACE protein within human respiratory epithelial cells. This binding was robustly observed through both co-immunoprecipitation and immunofluorescence assays, indicating a specific molecular association. Crucially, treatment with Thymosin-α1 led to a significant downregulation of ACE2 expression in these cells. This reduction in ACE2 expression was observed in a dose- and time-dependent manner, demonstrating a regulated biological response. These findings indicate that Thymosin-α1 can modulate key components of the renin-angiotensin system at the cellular level.
Why It Matters
This research highlights a novel mechanism by which Thymosin-α1 can influence respiratory epithelial cell biology, specifically by modulating ACE2 expression. Given that ACE2 serves as a primary entry receptor for SARS-CoV-2 and other respiratory viruses, this downregulation could have significant implications for host susceptibility and viral pathogenesis. These findings suggest a potential therapeutic role for Thymosin-α1 in managing respiratory viral infections or conditions where ACE2 modulation is beneficial. Future studies should explore these effects in vivo, investigate the precise molecular pathways involved, and assess the clinical relevance of Thymosin-α1 in human respiratory diseases.